{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-021037","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.278231+00:00","generated_at":"2026-06-17T23:32:54.822802+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"NeuroOne holds annual meeting; elects directors Mathiesen and Andrle, ratifies auditor","bullets":["Annual meeting held March 16, 2023; 9,719,474 shares (59.83%) represented.","Jeffrey Mathiesen re-elected as Class III director: 4,309,601 votes for, 268,402 withheld.","Edward Andrle re-elected as Class III director: 3,474,438 votes for, 1,103,565 withheld.","Baker Tilly U.S., LLP ratified as independent auditor for FY ending Sept 30, 2023: 9,661,674 for, 45,763 against, 12,037 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-021037","json":"https://secwatch.observer/filing/0001213900-23-021037.json","markdown":"https://secwatch.observer/filing/0001213900-23-021037.md","text":"https://secwatch.observer/filing/0001213900-23-021037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/0001213900-23-021037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/ea175425-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:32:54.822802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7b5e57d0776d037c776b128f9b561bf89b9da76f","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-03-16 meeting.","evidence_excerpt":"Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 9,661,674 45,763 12,037","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/0001213900-23-021037-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"},{"claim_id":"afb5c822abe1b6dcadeb487d55596f4e82d50a59","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp shareholders approved Election of Class III Directors at the 2023-03-16 meeting.","evidence_excerpt":"Proposal 1—Election of Directors Class III Nominees Votes For Votes Withheld Broker Non-Votes Jeffrey Mathiesen 4,309,601 268,402 5,141,471 Edward Andrle 3,474,438 1,103,565 5,141,471","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023021037/0001213900-23-021037-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}